Skip to main content
. 2014 Dec 10;33(1):104. doi: 10.1186/s13046-014-0104-7

Figure 2.

Figure 2

Prognostic value of KRAS status analysed either in tumor tissue or plasma samples by PNA-PCR. According to analyses of tumor tissue and plasma, KRAS status of each patient was categorized as: negative (KRAS wild type in tumor and matched plasma samples), discordant, (KRAS status discordant in tumor and matched plasma samples); positive (KRAS mutated either in tumor tissue and matched plasma samples.